Labotoxico
ActiveSummary
Labotoxico has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of -€28,201. Equity has been stable since 2019 (±1.8% per year). Its solvency ranks better than 74% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 20-11-1987 Normal situation
- Activity
- Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741and 5 others
- Joint committees
- 100 Aanvullend Paritair Comité voor de werklieden
- 201 Paritair Comité voor de zelfstandige kleinhandel · annual accounts 30-06-2022
- Establishment unit
- 2.033.163.847 8340 Damme, since 13-01-1988
- Financial year end
- 30 June
- Peppol
- Reachable since 21-10-2026
Board and ownership
- APOCHEMManaging director · permanent representative Cordonnier Jan
- Leenesonne Anne-MarieDirector · since 21-12-2017
- APOCHEM30%· score 882025 annual accounts of APOCHEM
- Holdings
- Shares in 1 company BIOCONTROL
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €134,214
- ▲ 243%
- Turnover
- ≈ €630,000
- estimated
- Loss
- €28,201
- ▼ 84.5%
- Equity
- €2.5m
- ▼ 1.1%
- Total assets
- €4.1m
- ▼ 2.2%
Score breakdownraises riskLiquidity: current ratio 1.78, cash €114,519Sector: Retail trade (NACE 47)lowers riskSize: total assets €4.1mFounded in 1987Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 81% of them on solvency, 58% on liquidity, 51% on profitability and 32% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 3 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: 3 loss-making years in a rowloss in financial year 2025 -€28,201 View
- Positive: Result rose in 2025from -€181,887 to -€28,201 ▲ 84.5% View
- Caution: Lower net result than 88% of companies in retail tradesector median €27,601 · 12,766 companies -€28,201 View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Recent changes
- · Gazette deed 1 director appointed, 2 directors resigning, 2 reappointedChange of role: APOCHEM, from director to afgevaardigd en gedelegeerd bestuurder · Resignation: Leenesonne Anne-Marie (director) · Reappointments: Leenesonne Anne-Marie (niet statutaire bestuurders) and APOCHEM (niet statutaire bestuurders)
- · Gazette deed Resignation: Apochem NV (director)Permanent representative: Jan Cordonnier
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Labotoxico: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €1.4m and €11m, founded between 1982 and 1999.
| Company | Total assets | Gross margin |
|---|---|---|
| Labotoxico Damme | €4.1m | €0.1m |
| bonyf Knokke-Heist | €3.4m | €0.06m |
| Decover Waregem | €2.7m | €0.09m |
| BARBIER M-INVEST Beveren-Kruibeke-Zwijndrecht | €1.4m | €0.1m |
| PHARMACIE ANTOINE Montigny-le-Tilleul | €1.8m | €0.5m |
| DYNAMIC Oostende | €3.5m | €0.06m |
| VICAJA Roeselare | €10.8m | €0.2m |
Key facts about Labotoxico
- What is the company number of Labotoxico?
- The company number of Labotoxico is 0432.685.722. The VAT number is the same number with BE in front: BE 0432.685.722.
- Where is Labotoxico based?
- The registered office is at Dorpsstraat 110, 8340 Damme.Company details
- What does Labotoxico do?
- According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
- What is the legal form of Labotoxico?
- The legal form of Labotoxico is Public limited company (NV).
- When was Labotoxico founded?
- Labotoxico was founded on 20-11-1987.
- Is Labotoxico still active?
- Yes, Labotoxico is an active enterprise in the KBO register.
- How many employees does Labotoxico have?
- Labotoxico had an average of 0.3 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
- Which joint committee does Labotoxico fall under?
- In its 30-06-2022 annual accounts, Labotoxico states joint committees 100 (Aanvullend Paritair Comité voor de werklieden) and 201 (Paritair Comité voor de zelfstandige kleinhandel).
- What is the turnover of Labotoxico?
- The turnover in financial year 2025 is ≈ €630,000. This figure is estimated from the gross margin of €134,214 and 51 comparable companies (NACE 477). It probably lies between €430,000 and €1.2m.
- Is Labotoxico profitable?
- In financial year 2025, Labotoxico made a loss of €28,201.
- Where can I find the annual accounts of Labotoxico?
- Labotoxico filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Labotoxico due?
- Labotoxico must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.